Aspyrian Therapeutics

Aspyrian Therapeutics

Aspyrian Therapeutics

Rakuten Aspyrian is a biotechnology company that develops tumor-targeted precision therapies.
Type
B2b
Raised
$189.1M
Follow us
Alexa global traffic share
Latest funding Show all
$134,000,000
Venture capital (Series C) - 2018
Rakuten SBI Group
$15,100,000
Venture capital (Series B) - 2017
Hiroshi Mikitani
Team Size
10+
Employees
$15,100,000 Venture capital (Series B)
San Diego Business Journal

Aspyrian Therapeutics Raises $15.1 Million

$40,000,000 Venture capital (Series B)
BioWorld , FinSMEs

Aspyrian draws $40M series B from Japanese Internet mogul

Health